而緯創於29日除權息隔天即出現上漲4.1%的填權息行情,目前還原股價來到2011年底以來新高;外資看好緯創接單狀況佳,下半年表現優於同業,ROE將反彈;另外,以色列醫療器材廠Integrity Applications宣布GlucoTrack model DF-F無創血糖儀的製造跟售後服務將委託緯創負責,預估2014年下半將可望正式投產,在基本面看好以及跨產業利多話題加持下表現可期。可留意價平的永豐AP(079072),成交量大隱波穩定。
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
留言列表